NMT MEDICAL INC

Aktie
WKN:  903047 ISIN:  US6292941092
Keine aktuellen Kursdaten verfügbar
Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Marktkapitalisierung *
-
Streubesitz
-
KGV
-
Index-Zuordnung
-
NMT MEDICAL INC Chart
Werbung

Mehr Nachrichten kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Termine

Keine Termine bekannt.

Prognose & Kursziel

Keine aktuellen Prognosen oder Kursziele bekannt.

Stammdaten

Aktienanzahl 16,02 Mio.
Aktientyp Stammaktie

Community-Beiträge zu NMT MEDICAL INC

  • Community-Beiträge
  • Aktuellste Threads
Avatar des Verfassers
0815ax
...nur noch eine Frage der Zeit
0.9 schon mal um die "Ecke"
Avatar des Verfassers
0815ax
?? heute Ziel 1.00 USD (siehe auch #72)
http://www.ariva.de/_t72764?pnr=9400082#jump9400082
Avatar des Verfassers
0815ax
NMTI Enters $2M Credit Agreement
NMT Medical Announces New $2 Million Credit Facility Date : 01/06/2011 @ 7:30AM Source : MarketWire Stock : NMT Medical (NMTI) http://ih.advfn.com/p.php?pid=nmona&article=45903874 NMT Medical, Inc. (NASDAQ: NMTI) today announced that it has entered into a credit agreement with LSQ Funding Group, L.C., a Florida-based firm that specializes in providing financing to small- and medium-sized businesses. The asset-based credit facility provides for borrowings up to $2 million for working capital requirements and other general corporate purposes. The credit facility has a one-year term and is subject to a borrowing base calculated as a percentage of domestic accounts receivable that are pledged as collateral against the loan. Richard E. Davis, NMT's Chairman, President and Chief Executive Officer, said, "This non-equity based credit facility, which replaces the credit arrangement with Silicon Valley Bank that we recently terminated, provides NMT with the necessary working capital required to fund its ongoing operations. We continue to tightly manage our expenses while working closely with the U.S. Food and Drug Administration to evaluate our potential next steps relating to patent foramen ovale (PFO) treatment for the stroke and transient ischemic attack (TIA) indications. In addition, we are continuing to evaluate all strategic options."
Avatar des Verfassers
0815ax
i

Jetzt anmelden und diskutieren Registrieren Login
Zum Thread wechseln

Häufig gestellte Fragen zur NMT MEDICAL INC Aktie und zum NMT MEDICAL INC Kurs

Nein, NMT MEDICAL INC zahlt keine Dividenden.